Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer’s disease: a meta-analysis and systematic review
- DOI
- 10.4103/1673-5374.335832
- Published
- 2022
- Container
- Neural Regeneration Research
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.4103/1673-5374.335832,
title = {Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer’s disease: a meta-analysis and systematic review},
author = {Li-Dian Chen and Wei-Lin Liu and Hua-Wei Lin and Miao-Ran Lin and Yan Yu and Huan-Huan Liu and Ya-Ling Dai and Le-Wen Chen and Wei-Wei Jia and Xiao-Jun He and Xiao-Ling Li and Jing-Fang Zhu and Xie-Hua Xue and Jing Tao},
year = {2022},
journal = {Neural Regeneration Research},
doi = {10.4103/1673-5374.335832},
url = {https://doi.org/10.4103/1673-5374.335832}
}RIS
TY - JOUR TI - Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer’s disease: a meta-analysis and systematic review AU - Li-Dian Chen AU - Wei-Lin Liu AU - Hua-Wei Lin AU - Miao-Ran Lin AU - Yan Yu AU - Huan-Huan Liu AU - Ya-Ling Dai AU - Le-Wen Chen AU - Wei-Wei Jia AU - Xiao-Jun He AU - Xiao-Ling Li AU - Jing-Fang Zhu AU - Xie-Hua Xue AU - Jing Tao PY - 2022 JO - Neural Regeneration Research DO - 10.4103/1673-5374.335832 UR - https://doi.org/10.4103/1673-5374.335832 ER -
APA
Chen, L., Liu, W., Lin, H., Lin, M., Yu, Y., Liu, H., Dai, Y., Chen, L., Jia, W., He, X., Li, X., Zhu, J., Xue, X., & Tao, J. (2022). Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer’s disease: a meta-analysis and systematic review. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.335832
Source records
- crossref · retrieved 2026-09-26T15:14:32.348Z